Skip to main content
Log in

Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Sixty postmenopausal women suffering from genuine stress incontinence were recruited into a double-blind study comparing the effects of oral and intravaginal estrogens and placebo, alone and in combination with the alpha-adrenoreceptor stimulant drug phenyl-propanolamine (PPA). Side effects were more common with orally administered estrogen, whereas symptomatic improvements were greater than the vaginal route. Plasma estrone and estradiol were both elevated more when estrogen was given by the oral (x 3–4) than vaginal (x 2) route, although the estradiol/estrone ratio was lower with oral therapy; the biochemical alterations increased with increasing chronological age and menopausal age, and were slightly enhanced by the concurrent administration of PPA. Diurnal and nocturnal urinary frequency were both reduced to a greater extent with vaginal than oral estrogen treatment, and more when used with PPA. Stress incontinence was improved subjectively in all treatment groups, although objective improvement was maximal in those treated with vaginal estrogen plus PPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Smith P. Age changes in the female urethra.Br J Urol 1972; 42: 667–676

    Google Scholar 

  2. van Keep P, Lauritzen C.Aging and Oestrogens, Basel Karger, 1973

    Google Scholar 

  3. Hilton P. Urethral pressure measurement by microtransducer: observations on themethodology, the pathophysiology of genuine stress incontinence, and the effects of its treatment in the female [MD Thesis]. Newcastle upon Tyne: University of Newcastle upon Tyne, 1981

    Google Scholar 

  4. Caine M, Raz S. The role of female hormones in stress incontinence. In: Proceedings of the 16th Congress of the International Society of Urologists. Amsterdam. 1973: 30

  5. Walter S, Wolf H, Barlebo H, Kaalund-Jensen H. Urinary incontinence in post-menopausal women treated with oestrogens: a double-blind clinical trial.Urol Int 1970; 33: 135–143

    Google Scholar 

  6. Wilson PD, Faragher B, Butler B, Bu'Lock D, Robinson EL, Brown ADG. Treatment with oral piperazine sulphate for genuine stress incontinence in post-menopausal women.Br J Obstet Gynaecol 1987; 94:568–574

    Google Scholar 

  7. Rud T. The effects of oestrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women.Acta Obstet Gynecol. Scand. 1980; 59: 265–270

    Google Scholar 

  8. Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence.Br J Obstet Gynaecol 1983; 90: 940–944

    Google Scholar 

  9. Tanagho EA, Meyers FH, Smith D. Urethral resistance: its components and implications. I. Smooth muscle component.Invest Urol 1969; 7: 136–149

    Google Scholar 

  10. Donker PJ, Ivanovici F, Noach EL. Analysis of the urethral pressure profile by means of electromyography and the administration of drugs.Br J Urol 1972; 40: 180–193

    Google Scholar 

  11. Ek A, Alm P, Andersson K-E, Persson CGA. Adrenergic and cholinergic nerves of the human urethra and urinary bladder. A histochemical study.Acta Physiol Scand 1977; 90: 345–352

    Google Scholar 

  12. Gosling JA, Dixon J, Lendon RG. The autonomic innervation of the human male and female bladder neck and proximal urethra.J. Urol 1977; 118:302–305

    Google Scholar 

  13. Stewart BH, Banowsky LHW, Montague DK. Stress incontinence: conservative therapy with sympatomimetic drugs.J. Urol 1976; 115:558–559

    Google Scholar 

  14. Montague DK, Stewart BH. Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence.J. Urol 1979; 122: 198–199

    Google Scholar 

  15. Hilton P, Stanton SL, The use of midodrine in genuine stress incontinence. In: Proceedings of the XIIth annual meeting of the International Continence Society, Leiden, Netherlands. 1982; 23–24

  16. Hilton P, Stanton SL. Urethral pressure measurement by microtransducer: the results in normal women and in those with genuine stress incontinence.Br J Obstet Gynaecol 1983; 90: 919–934

    Google Scholar 

  17. Mayne CJ, Hilton P. The short pad-test: standardisation of method and a comparison with the one hour test.Neurourol Urodyn 1988; 7: 443–446

    Google Scholar 

  18. Abrams P, Blaivas JG, Stanton SL, Andersen JT. Standardisation of terminology of lower urinary tract function.Neurourol Urodyn 1988; 7: 403–427

    Google Scholar 

  19. Schreiter F, Fuchs P, Stockamp K. Estrogenic sensitivity of alphareceptors in the urethra musculature.Urol Int 1976; 31: 13–19

    Google Scholar 

  20. Ford SP, Reynolds LP, Farley DB, Bhatnagar RK, van Orden DE. Interaction of ovarian steroids and periarterial alpha1-adrenergic receptors in altering uterine blood flow during the estrous cycle of gilts.Am J. Obstet Gynecol 1984; 150: 480–484

    Google Scholar 

  21. Ek A, Andersson K-E, Gullberg B, Ulmsten U. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.Zentralbe Gynakol 1980; 102: 839–844

    Google Scholar 

  22. Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphinteric insufficiency in post-menopausal females: treatment with phenylpropanolamine and estriol separately and in combination.Urol Int 1984; 39: 211–216

    Google Scholar 

  23. Kiesswetter H, Hennrich F, Englisch M. Clinical and urodynamic assessment of pharmacologic therapy of stress incontinence.Urol Int 1983; 38: 58–63

    Google Scholar 

  24. Ryan KJ, Engel LL. The interconversion of oestrone and oestradiol by human tissue slices.Endrocinology 1953; 52: 287–291

    Google Scholar 

  25. Rigg LA, Hermann H, Yen SC. Absorption of estrogens from vaginal creams.N. Engl J Med 1978; 298: 195–197

    Google Scholar 

  26. Englund DE, Johansson EDB. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin),Br J Obstet Gynaecol 1978; 85: 957–964

    Google Scholar 

  27. Whitehead MI, Minardi J, Kitchen Y, Sharples MJ. Systematic absorption of estrogen from Premarin vaginal cream. In: Cooke ID, ed. The role of estrogen/progrestogen in the management of the menopause. Lancaster: MTP Press, 1978: 63–75

    Google Scholar 

  28. Paterson MEL, Wade-Evans T, Sturdee DW, Thom MH, Studd JW. Endometrial disease after treatment with oetrogens and progesterones in the climacteric.Br Med J 1980; 822–824

  29. Thom MH, White PJ, Williams RM, Sturdee DW, Paterson MEL, Wade-Evans T, Studd JWW. Prevention and treatment of endometrical pathology in climacteric women receiving oestrogen therapy. Lancet II: 455–457

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hilton, P., Tweddell, A.L. & Mayne, C. Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence. Int Urogynecol J 1, 80–86 (1990). https://doi.org/10.1007/BF00600027

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00600027

Keywords

Navigation